Mechanistic Research on Neuromodulation for Substance Use Disorders Treatment (R61/R33 Clinical Trial Optional)
This grant opportunity seeks to fund clinical research focused on non-invasive brain stimulation (NIBS) to uncover new targets that relate to neurobiological, cognitive, and behavioral responses linked to substance use disorders (SUD). The aim is to find responses that occur before clinical outcomes like reduced cravings or drug use. The research is expected to be exploratory, accepting risks …
Source
Award
Dates
Keywords
Supporting Links
Documents
Similar Opportunities
-
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
National Institutes of Health
-
NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
National Institutes of Health
-
Faculty Scholar Award
Ruth K. Broad Biomedical Research Foundation, Inc.
-
Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
National Institutes of Health
-
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
National Institutes of Health
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers